Inhibition of growth of normal murine granulocytes by cocultured acute leukemic cells

Autor: AM Miller, PL Page, BL Hartwell, SM Robinson

Publikováno v: Blood. 50(5)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2db4b947d5b683e5e6da8e41945e27d4
https://pubmed.ncbi.nlm.nih.gov/561633

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cross-sections for ⁴³ Sc, ^44m Sc, and ^44g Sc from two heavy ion reactions.

Autor: Miller AM; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, 46556, IN, USA., Wilkinson JT; Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, Livermore, 95550, IN, USA., Brown GM; Department of Physics & Astronomy, University of Notre Dame, Notre Dame, 46556, IN, USA., Gan J; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, 46556, IN, USA., Manukyan K; Department of Physics & Astronomy, University of Notre Dame, Notre Dame, 46556, IN, USA., Jin Y; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, 46556, IN, USA., Peaslee GF; Department of Physics & Astronomy, University of Notre Dame, Notre Dame, 46556, IN, USA. Electronic address: gpeaslee@nd.edu.

Publikováno v: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine [Appl Radiat Isot] 2025 Jan; Vol. 215, pp. 111560. Date of Electronic Publication: 2024 Oct 28.

Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study.

Autor: Kleber TJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sherry AD; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arifin AJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Division of Radiation Oncology, London Health Sciences Centre/Western University, London, Canada., Kupferman GS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kouzy R; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jaoude JA; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Lin TA; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Beck EJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Miller AM; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Passy AH; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mccaw ZR; Insitro, South San Francisco, CA, USA.; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Msaouel P; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ludmir EB; Department of Gastrointestinal Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Dec 06. Date of Electronic Publication: 2024 Dec 06.

Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials.

Autor: Sherry AD; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lin TA; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland., McCaw ZR; Insitro, South San Francisco, California; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Beck EJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kouzy R; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Abi Jaoude J; Department of Radiation Oncology, Stanford University, Stanford, California., Passy AH; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Miller AM; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kupferman GS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fuller CD; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Thomas CR Jr; Department of Radiation Oncology and Applied Sciences, Dartmouth Cancer Center, Geisel School of Medicine, Lebanon, New Hampshire., Koay EJ; Departments of Gastrointestinal Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tang C; Departments of Genitourinary Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Msaouel P; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ludmir EB; Departments of Gastrointestinal Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: ebludmir@mdanderson.org.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Dec 01; Vol. 120 (5), pp. 1239-1244. Date of Electronic Publication: 2024 Sep 30.